GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » Common Stock

Respiri (ASX:RSH) Common Stock : A$138.61 Mil (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Respiri Common Stock?

Respiri's quarterly common stock increased from Dec. 2022 (A$130.36 Mil) to Jun. 2023 (A$132.10 Mil) and increased from Jun. 2023 (A$132.10 Mil) to Dec. 2023 (A$138.61 Mil).

Respiri's annual common stock increased from Jun. 2021 (A$127.09 Mil) to Jun. 2022 (A$128.84 Mil) and increased from Jun. 2022 (A$128.84 Mil) to Jun. 2023 (A$132.10 Mil).


Respiri Common Stock Historical Data

The historical data trend for Respiri's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiri Common Stock Chart

Respiri Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.04 113.70 127.09 128.84 132.10

Respiri Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 127.09 128.84 130.36 132.10 138.61

Respiri Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Respiri (ASX:RSH) Business Description

Traded in Other Exchanges
Address
432 St Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

Respiri (ASX:RSH) Headlines

No Headlines